MedTrace Logo

Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment

NCT06414018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-01-14

No results posted yet for this study

Summary

The equivalent dose of sufentanil and afentanil combined with laryngeal mask was used for complex bronchoscopy to observe the intraoperative effect and the influence on the recovery of patients

Conditions

  • Effect of Drug

Interventions

DRUG

Alfentanil

alfentanil 10ug/kg is used for anesthesia induction

Sponsors & Collaborators

  • Xinxiang Central Hospital

    collaborator OTHER

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • aijun xu, Dr · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-20
Primary Completion
2024-12-25
Completion
2024-12-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06414018 on ClinicalTrials.gov